Michael J Duffy

Michael J Duffy

UNVERIFIED PROFILE

Are you Michael J Duffy?   Register this Author

Register author
Michael J Duffy

Michael J Duffy

Publications by authors named "Michael J Duffy"

Are you Michael J Duffy?   Register this Author

99Publications

1578Reads

10Profile Views

Biomarkers for prostate cancer: prostate-specific antigen and beyond.

Authors:
Michael J Duffy

Clin Chem Lab Med 2020 Feb;58(3):326-339

UCD Clinical Research Centre, St. Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/cclm-2019-0693DOI Listing
February 2020

COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells.

Breast Cancer Res Treat 2020 Jan 19;179(1):47-56. Epub 2019 Sep 19.

UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05435-1DOI Listing
January 2020

Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients.

Clin Chem 2019 Oct 17;65(10):1228-1238. Epub 2019 Jul 17.

Medical Oncology Department, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2019.303644DOI Listing
October 2019

Tissue and Blood Biomarkers in Lung Cancer: A Review.

Adv Clin Chem 2018;86:1-21. Epub 2018 May 30.

Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.acc.2018.05.001DOI Listing
May 2019

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells.

Cancers (Basel) 2019 Apr 17;11(4). Epub 2019 Apr 17.

Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin D09 NR58, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11040548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520724PMC
April 2019

HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells.

Cancers (Basel) 2019 Feb 8;11(2). Epub 2019 Feb 8.

Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, 9 Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11020197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406301PMC
February 2019

Circulating tumour DNA as a cancer biomarker.

Authors:
Michael J Duffy

Ann Clin Biochem 2019 01 5;56(1):42-48. Epub 2018 Sep 5.

1 UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0004563218798401DOI Listing
January 2019

The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells.

Transl Oncol 2018 Dec 6;11(6):1343-1349. Epub 2018 Sep 6.

UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; UCD Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2018.08.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132178PMC
December 2018

Prognostic and predictive biomarkers in breast cancer: Past, present and future.

Semin Cancer Biol 2018 10 4;52(Pt 1):56-73. Epub 2017 Sep 4.

UCD Clinical Research Centre, St. Vincent's University Hospital, Dublin and UCD School of Medicine, Conway Institute, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.08.010DOI Listing
October 2018

Mutant p53 in breast cancer: potential as a therapeutic target and biomarker.

Breast Cancer Res Treat 2018 Jul 21;170(2):213-219. Epub 2018 Mar 21.

Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4753-7DOI Listing
July 2018

Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA.

Tumour Biol 2018 May;40(5):1010428318776169

2 UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1010428318776169DOI Listing
May 2018

Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.

Cancer Lett 2018 02 22;414:99-106. Epub 2017 Oct 22.

UCD School of Medicine, University College Dublin, Dublin 4, Ireland; UCD Clinical Research Centre, St. Vincent's University Hospital, Dublin 4, Ireland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2017.09.053DOI Listing
February 2018

Mutant p53 as a target for cancer treatment.

Eur J Cancer 2017 09 28;83:258-265. Epub 2017 Jul 28.

Department of Medical Oncology, St Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.06.023DOI Listing
September 2017

Use of Multiparameter Tests for Identifying Women with Early Breast Cancer Who Do Not Need Adjuvant Chemotherapy.

Clin Chem 2017 04 10;63(4):804-806. Epub 2017 Feb 10.

Medical Oncology Department, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2016.267161DOI Listing
April 2017

Vitamin D receptor as a target for breast cancer therapy.

Endocr Relat Cancer 2017 04 17;24(4):181-195. Epub 2017 Feb 17.

UCD School of MedicineConway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0463DOI Listing
April 2017

Vitamin D analogues: Potential use in cancer treatment.

Crit Rev Oncol Hematol 2017 Apr 22;112:190-197. Epub 2017 Feb 22.

Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.02.015DOI Listing
April 2017

Validated biomarkers: The key to precision treatment in patients with breast cancer.

Breast 2016 Oct 9;29:192-201. Epub 2016 Aug 9.

UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; Medical Oncology Department, St Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2016.07.009DOI Listing
October 2016

The ADAMs family of proteases as targets for the treatment of cancer.

Cancer Biol Ther 2016 08 26;17(8):870-80. Epub 2016 Apr 26.

b UCD School of Medicine and Medical Science , Conway Institute of Biomolecular and Biomedical Research, University College Dublin , Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2016.1177684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004698PMC
August 2016

Biomarkers in Breast Cancer: Where Are We and Where Are We Going?

Adv Clin Chem 2015 23;71:1-23. Epub 2015 Jun 23.

Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.acc.2015.05.001DOI Listing
April 2016

Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells.

Endocr Relat Cancer 2016 Apr 1;23(4):323-34. Epub 2016 Mar 1.

School of MedicineUniversity College Dublin, Ireland UCD Clinical Research CentreSt. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
https://erc.bioscientifica.com/view/journals/erc/23/4/323.xm
Publisher Site
http://dx.doi.org/10.1530/ERC-16-0068DOI Listing
April 2016

Use of Biomarkers in Screening for Cancer.

Authors:
Michael J Duffy

Adv Exp Med Biol 2015 ;867:27-39

Clinical Research Centre, St Vincent's University Hospital, Elm Park, Dublin, 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-94-017-7215-0_3DOI Listing
March 2016

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.

Int J Gynecol Cancer 2016 Jan;26(1):43-51

*Department of Clinical Biochemistry, University of Copenhagen North Zealand Hospital, Hillerød, Denmark; †Clinical Research Centre, St Vincent's University Hospital and UCD School of Medicine and Medical Science, Conway Institute of Bimolecular and Biomedical, Research, University College Dublin, Dublin, Ireland; ‡Department of Gynecological Oncology, University Medical, Centre Utrecht, Utrecht, the Netherlands; §Department of Oncology, Gynecologic Oncology Unit, Uppsala, University Hospital, Uppsala, Sweden; ∥Division of Cancer Medicine, Department of Gynecologic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ¶Department of Gynecology, Leiden University Medical Center, Leiden, The Netherlands; #Department of Clinical Biochemistry, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom; **Senior Expert Clinical Laboratories, PUM Netherlands Senior Experts, Heemstede, the Netherlands; ††Norwegian Quality Improvement of Primary Care Laboratories (NOKLUS), Section for General Practice, University of Bergen, Bergen, Norway; ‡‡Emeritus Scientist from Abbott, Limburg, Germany; §§Consultant, Centro Ippocrate, Bogliasco, Italy; ∥∥Department of Clinical Biochemistry, Center of Oncology - M. Sklodowska-Curie Memorial Institute, Cracow Division, Poland; ¶¶Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark; and ##Laboratory of Biochemistry, Hospital Clinico, Barcelona, Spain.

View Article

Download full-text PDF

Source
https://www.diva-portal.org/smash/get/diva2:900469/FULLTEXT0
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000586DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679342PMC
January 2016

ADAM10: a new player in breast cancer progression?

Br J Cancer 2015 Sep 18;113(6):945-51. Epub 2015 Aug 18.

UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578086PMC
September 2015

Validation of new cancer biomarkers: a position statement from the European group on tumor markers.

Clin Chem 2015 Jun 16;61(6):809-20. Epub 2015 Apr 16.

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2015.239863DOI Listing
June 2015

PSA in screening for prostate cancer: more good than harm or more harm than good?

Authors:
Michael J Duffy

Adv Clin Chem 2014 ;66:1-23

View Article

Download full-text PDF

Source
November 2014

ADAM10 and ADAM17: New players in trastuzumab tesistance.

Oncotarget 2014 Nov;5(22):10963-4

Education and Research Centre, St. Vincent's University Hospital, Dublin and UCD School of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294375PMC
http://dx.doi.org/10.18632/oncotarget.2794DOI Listing
November 2014

cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?

Expert Opin Ther Targets 2014 Sep 1;18(9):999-1009. Epub 2014 Aug 1.

Dublin City University, National Institute for Cellular Biotechnology , Dublin 9 , Ireland +00353 1 7007497 ; +00353 1 7005484 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.2014.938050DOI Listing
September 2014

Precision treatment for cancer: role of prognostic and predictive markers.

Crit Rev Clin Lab Sci 2014 Feb 16;51(1):30-45. Epub 2014 Jan 16.

Clinical Research Centre .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10408363.2013.865700DOI Listing
February 2014

Companion biomarkers: paving the pathway to personalized treatment for cancer.

Clin Chem 2013 Oct 8;59(10):1447-56. Epub 2013 May 8.

UCD School of Medicine and Medical Science, Conway Institute, University College Dublin, Ireland;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2012.200477DOI Listing
October 2013

Monitoring response to therapy in patients with cancer: is circulating DNA the answer?

Ann Transl Med 2013 Oct;1(3):24

1 UCD School of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin, Ireland ; 2 Clinical Research Centre, 3 Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2013.07.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200673PMC
October 2013

Exploring the glycosylation of serum CA125.

Int J Mol Sci 2013 Jul 26;14(8):15636-54. Epub 2013 Jul 26.

NIBRT GlycoScience Group, National Institute for Bioprocessing Research and Training, Mount Merrion, Blackrock, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms140815636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759877PMC
July 2013

Tumor markers in clinical practice: a review focusing on common solid cancers.

Authors:
Michael J Duffy

Med Princ Pract 2013 15;22(1):4-11. Epub 2012 May 15.

Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/338393
Publisher Site
http://dx.doi.org/10.1159/000338393DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586699PMC
June 2013

Targeted therapy for triple-negative breast cancer: where are we?

Int J Cancer 2012 Dec 7;131(11):2471-7. Epub 2012 Jun 7.

UCD Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27632DOI Listing
December 2012

Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours.

Breast Cancer Res Treat 2012 Dec 2;136(3):717-27. Epub 2012 Nov 2.

Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2260-9
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2260-9DOI Listing
December 2012

Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?

Authors:
Michael J Duffy

Ann Clin Biochem 2011 Jul 27;48(Pt 4):310-6. Epub 2011 Apr 27.

Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/acb.2011.010273DOI Listing
July 2011

The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory.

Ann Clin Biochem 2011 Jul;48(Pt 4):295-9

Department of Clinical Biochemistry, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/acb.2011.011117DOI Listing
July 2011

The role of S100 genes in breast cancer progression.

Tumour Biol 2011 Jun 14;32(3):441-50. Epub 2010 Dec 14.

Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13277-010-0137-2
Publisher Site
http://dx.doi.org/10.1007/s13277-010-0137-2DOI Listing
June 2011

Use of molecular markers for predicting therapy response in cancer patients.

Cancer Treat Rev 2011 Apr 3;37(2):151-9. Epub 2010 Aug 3.

Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372100012
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2010.07.004DOI Listing
April 2011

Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.

Int J Cancer 2011 Jan;128(1):3-11

Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin and UCD School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25654DOI Listing
January 2011

Intracellular and extracellular microRNAs in breast cancer.

Clin Chem 2011 Jan 8;57(1):18-32. Epub 2010 Nov 8.

School of Pharmacy and Pharmaceutical Sciences and Molecular Therapeutics for Cancer Ireland (MTCI), Trinity College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2010.150730DOI Listing
January 2011

CA 15-3: uses and limitation as a biomarker for breast cancer.

Clin Chim Acta 2010 Dec 8;411(23-24):1869-74. Epub 2010 Sep 8.

Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00098981100055
Publisher Site
http://dx.doi.org/10.1016/j.cca.2010.08.039DOI Listing
December 2010

Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients.

Glycobiology 2010 Oct 24;20(10):1283-8. Epub 2010 Jun 24.

UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
https://academic.oup.com/glycob/article-lookup/doi/10.1093/g
Publisher Site
http://dx.doi.org/10.1093/glycob/cwq090DOI Listing
October 2010

Activated phosphoinositide 3-kinase/AKT signaling confers resistance to trastuzumab but not lapatinib.

Mol Cancer Ther 2010 Jun 25;9(6):1489-502. Epub 2010 May 25.

Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095-7077, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-09-1171DOI Listing
June 2010

Prioritization of candidate protein biomarkers from an in vitro model system of breast tumor progression toward clinical verification.

J Proteome Res 2010 Mar;9(3):1450-9

UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/pr900989qDOI Listing
March 2010

Use of Biomarkers in Screening for Cancer.

Authors:
Michael J Duffy

EJIFCC 2010 Mar 25;21(1):1-12. Epub 2010 Mar 25.

Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin 4, UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin , Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975170PMC
March 2010

Survivin: a new target for anti-cancer therapy.

Cancer Treat Rev 2009 Nov 25;35(7):553-62. Epub 2009 Jun 25.

Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4258, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2009.05.003DOI Listing
November 2009

Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.

Int J Cancer 2009 May;124(9):2088-97

UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24159DOI Listing
May 2009

The role of ADAMs in disease pathophysiology.

Clin Chim Acta 2009 May;403(1-2):31-6

Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2009.01.007DOI Listing
May 2009

Role of ADAMs in cancer formation and progression.

Clin Cancer Res 2009 Feb;15(4):1140-4

Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, UCD School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1585DOI Listing
February 2009

A personalized approach to cancer treatment: how biomarkers can help.

Clin Chem 2008 Nov 18;54(11):1770-9. Epub 2008 Sep 18.

Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://www.clinchem.org/cgi/doi/10.1373/clinchem.2008.110056
Publisher Site
http://dx.doi.org/10.1373/clinchem.2008.110056DOI Listing
November 2008

Use of a panel of novel genes for differentiating breast cancer from non-breast tissues.

Tumour Biol 2007 5;28(6):312-7. Epub 2008 Feb 5.

Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000115527DOI Listing
May 2008

Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.

Clin Cancer Res 2008 May;14(9):2681-9

UCD School of Biomolecular and Biomedical Science and UCD School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1760DOI Listing
May 2008

Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer.

Cancer Genomics Proteomics 2007 May-Jun;4(3):121-34

UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, and Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
November 2007

Role of tumor markers in patients with solid cancers: A critical review.

Authors:
Michael J Duffy

Eur J Intern Med 2007 May;18(3):175-84

Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin 4, UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin and Dublin Molecular Medicine Institute, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2006.12.001DOI Listing
May 2007

Survivin: a promising tumor biomarker.

Cancer Lett 2007 Apr 1;249(1):49-60. Epub 2007 Feb 1.

Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2006.12.020DOI Listing
April 2007

ADAM-17 expression in breast cancer correlates with variables of tumor progression.

Clin Cancer Res 2007 Apr;13(8):2335-43

Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2092DOI Listing
April 2007

Lipophilin B: A gene preferentially expressed in breast tissue and upregulated in breast cancer.

Int J Cancer 2007 Mar;120(5):1087-92

Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22471DOI Listing
March 2007

Breast cancer proteomics: clinical perspectives.

Expert Opin Biol Ther 2007 Feb;7(2):209-19

UCD Conway Institute, UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.7.2.209DOI Listing
February 2007

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

Clin Cancer Res 2006 Nov;12(21):6421-31

UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College, Dublin, and Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0480DOI Listing
November 2006

Serum tumor markers in breast cancer: are they of clinical value?

Authors:
Michael J Duffy

Clin Chem 2006 Mar 12;52(3):345-51. Epub 2006 Jan 12.

Department of Nuclear Medicine, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2005.059832DOI Listing
March 2006

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

Tumour Biol 2005 Nov-Dec;26(6):281-93

Laboratory of Biochemistry, Hospital Clinic, Medical School, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000089260DOI Listing
December 2005

Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes.

Tumour Biol 2005 Jul-Aug;26(4):213-6. Epub 2005 Jul 6.

Department of Surgery, Medical Oncology and Nuclear Medicine, St. Vincent's University Hospital and Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/12/21/6410.ful
Web Search
http://www.karger.com/doi/10.1159/000086955
Publisher Site
http://dx.doi.org/10.1159/000086955DOI Listing
September 2005

Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response.

Expert Opin Biol Ther 2005 Aug;5(8):1069-83

Conway Institute of Biomolecular and Biomedical Research, Department of Pharmacology, Centre for Molecular Medicine, University College Dublin, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.5.8.1069DOI Listing
August 2005

Mammaglobin a in breast cancer: existence of multiple molecular forms.

Int J Cancer 2005 Apr;114(4):623-7

Department of Nuclear Medicine, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20780DOI Listing
April 2005

Predictive markers in breast and other cancers: a review.

Authors:
Michael J Duffy

Clin Chem 2005 Mar 6;51(3):494-503. Epub 2005 Jan 6.

Department of Nuclear Medicine, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2004.046227DOI Listing
March 2005

Evidence for the clinical use of tumour markers.

Authors:
Michael J Duffy

Ann Clin Biochem 2004 Sep;41(Pt 5):370-7

Department of Nuclear Medicine, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/0004563041731529DOI Listing
September 2004

The urokinase plasminogen activator system: role in malignancy.

Authors:
Michael J Duffy

Curr Pharm Des 2004 ;10(1):39-49

Department of Surgery, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612043453559DOI Listing
April 2004

Expression of ADAM-9 mRNA and protein in human breast cancer.

Int J Cancer 2003 Jul;105(6):754-61

Conway Institute of Biomolecular and Biomedical Sciences, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.11161
Publisher Site
http://dx.doi.org/10.1002/ijc.11161DOI Listing
July 2003

Metsulfuron methyl sorption-desorption in field-moist soils.

J Agric Food Chem 2003 Jun;51(12):3598-603

Swedish University of Agricultural Sciences, Department of Environmental Assessment, P.O. Box 7050, SE-750 07 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jf0210270DOI Listing
June 2003

The ADAMs family of proteins: from basic studies to potential clinical applications.

Thromb Haemost 2003 Apr;89(4):622-31

Dept of Nuclear Medicine, St Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
April 2003

Caspase 3 in breast cancer.

Clin Cancer Res 2003 Feb;9(2):738-42

Department of Medical Oncology, St. Vincent's University Hospital, University College Dublin, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
February 2003

Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies.

Authors:
Michael J Duffy

Clin Chem 2002 Aug;48(8):1194-7

Department of Nuclear Medicine, St. Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
August 2002

Mammaglobin a: a promising marker for breast cancer.

Clin Chem 2002 Aug;48(8):1362-4

Department of Nuclear Medicine, St. Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
August 2002

Increased prevalence of Brucella suis and pseudorabies virus antibodies in adults of an isolated feral swine population in coastal South Carolina.

J Wildl Dis 2002 Jul;38(3):653-6

Department of Microbiology, Franklin College of Arts and Sciences, University of Georgia, Athens, Georgia 30602, USA.

View Article

Download full-text PDF

Source
http://www.jwildlifedis.org/doi/10.7589/0090-3558-38.3.653
Publisher Site
http://dx.doi.org/10.7589/0090-3558-38.3.653DOI Listing
July 2002

Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers.

Authors:
Michael J Duffy

Biochem Soc Trans 2002 Apr;30(2):207-10

Department of Nuclear Medicine, St Vincent's University Hospital, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/DOI Listing
April 2002